Preliminary safety study of pioglitazone therapy for diabetes on macular thickness and vision in type 2 diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 03 Nov 2007 New trial record.
- 23 Oct 2007 Biomarkers information updated